These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
750 related articles for article (PubMed ID: 15846285)
1. Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation. Le Blanc K; Ringdén O Biol Blood Marrow Transplant; 2005 May; 11(5):321-34. PubMed ID: 15846285 [TBL] [Abstract][Full Text] [Related]
2. Immunomodulation by mesenchymal stem cells and clinical experience. Le Blanc K; Ringdén O J Intern Med; 2007 Nov; 262(5):509-25. PubMed ID: 17949362 [TBL] [Abstract][Full Text] [Related]
3. Mesenchymal stem cells: properties and role in clinical bone marrow transplantation. Le Blanc K; Ringdén O Curr Opin Immunol; 2006 Oct; 18(5):586-91. PubMed ID: 16879957 [TBL] [Abstract][Full Text] [Related]
4. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Lazarus HM; Koc ON; Devine SM; Curtin P; Maziarz RT; Holland HK; Shpall EJ; McCarthy P; Atkinson K; Cooper BW; Gerson SL; Laughlin MJ; Loberiza FR; Moseley AB; Bacigalupo A Biol Blood Marrow Transplant; 2005 May; 11(5):389-98. PubMed ID: 15846293 [TBL] [Abstract][Full Text] [Related]
5. Bone marrow-derived mesenchymal stem cells decrease acute graft-versus-host disease after allogeneic hematopoietic stem cells transplantation. Tian Y; Deng YB; Huang YJ; Wang Y Immunol Invest; 2008; 37(1):29-42. PubMed ID: 18214798 [TBL] [Abstract][Full Text] [Related]
6. Immunomodulatory effects of mesenchymal stem cells involved in favoring type 2 T cell subsets. Lu X; Liu T; Gu L; Huang C; Zhu H; Meng W; Xi Y; Li S; Liu Y Transpl Immunol; 2009 Dec; 22(1-2):55-61. PubMed ID: 19695330 [TBL] [Abstract][Full Text] [Related]
7. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]
8. Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease. Yañez R; Lamana ML; García-Castro J; Colmenero I; Ramírez M; Bueren JA Stem Cells; 2006 Nov; 24(11):2582-91. PubMed ID: 16873762 [TBL] [Abstract][Full Text] [Related]
10. Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis. Larghero J; Farge D; Braccini A; Lecourt S; Scherberich A; Foïs E; Verrecchia F; Daikeler T; Gluckman E; Tyndall A; Bocelli-Tyndall C Ann Rheum Dis; 2008 Apr; 67(4):443-9. PubMed ID: 17526552 [TBL] [Abstract][Full Text] [Related]
11. Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation. Maitra B; Szekely E; Gjini K; Laughlin MJ; Dennis J; Haynesworth SE; Koç ON Bone Marrow Transplant; 2004 Mar; 33(6):597-604. PubMed ID: 14716336 [TBL] [Abstract][Full Text] [Related]
12. Immunomodulatory effects of mesenchymal stem cells derived from adipose tissues in a rat orthotopic liver transplantation model. Wan CD; Cheng R; Wang HB; Liu T Hepatobiliary Pancreat Dis Int; 2008 Feb; 7(1):29-33. PubMed ID: 18234635 [TBL] [Abstract][Full Text] [Related]
13. Immunosuppression by mesenchymal stromal cells: from culture to clinic. Jones BJ; McTaggart SJ Exp Hematol; 2008 Jun; 36(6):733-41. PubMed ID: 18474304 [TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cells home to injured tissues when co-infused with hematopoietic cells to treat a radiation-induced multi-organ failure syndrome. Chapel A; Bertho JM; Bensidhoum M; Fouillard L; Young RG; Frick J; Demarquay C; Cuvelier F; Mathieu E; Trompier F; Dudoignon N; Germain C; Mazurier C; Aigueperse J; Borneman J; Gorin NC; Gourmelon P; Thierry D J Gene Med; 2003 Dec; 5(12):1028-38. PubMed ID: 14661178 [TBL] [Abstract][Full Text] [Related]
15. Immunosuppressive properties of cloned bone marrow mesenchymal stem cells. Xu G; Zhang L; Ren G; Yuan Z; Zhang Y; Zhao RC; Shi Y Cell Res; 2007 Mar; 17(3):240-8. PubMed ID: 17325691 [TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cells and their potential as cardiac therapeutics. Pittenger MF; Martin BJ Circ Res; 2004 Jul; 95(1):9-20. PubMed ID: 15242981 [TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cells prolong composite tissue allotransplant survival in a swine model. Kuo YR; Goto S; Shih HS; Wang FS; Lin CC; Wang CT; Huang EY; Chen CL; Wei FC; Zheng XX; Lee WP Transplantation; 2009 Jun; 87(12):1769-77. PubMed ID: 19543052 [TBL] [Abstract][Full Text] [Related]
18. Immunotherapy by allogeneic stem cell transplantation. Ringdén O Adv Cancer Res; 2007; 97():25-60. PubMed ID: 17419940 [TBL] [Abstract][Full Text] [Related]
19. Human mesenchymal stem cells inhibit antibody production induced in vitro by allostimulation. Comoli P; Ginevri F; Maccario R; Avanzini MA; Marconi M; Groff A; Cometa A; Cioni M; Porretti L; Barberi W; Frassoni F; Locatelli F Nephrol Dial Transplant; 2008 Apr; 23(4):1196-202. PubMed ID: 18029377 [TBL] [Abstract][Full Text] [Related]
20. Human-placenta-derived mesenchymal stem cells inhibit proliferation and function of allogeneic immune cells. Li C; Zhang W; Jiang X; Mao N Cell Tissue Res; 2007 Dec; 330(3):437-46. PubMed ID: 17899199 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]